Safety and Efficacy of TeaRx Xa Factor Direct Inhibitor Versus Enoxaparin as a Venous Thromboembolic Events (VTE) Prevention Following Total Knee Replacement

"Federal State Institution National Medical and Surgical Center n. a. N. I. Pirogov of the Ministry of Health of the Russian Federation", Moscow

SBEI HPE First Moscow State Medical University n.a. I.M. Sechenov Ministry of Health of the Russian Federation, Moscow

SHI of the city of Moscow City Clinical Hospital n.a. S.P. Botkin, Moscow

SHI of the Yaroslavl Region Emergency care hospital n. a. N. V. Solovyov, Yaroslavl

"St. Petersburg State Institution of Health City Hospital № 2", Saint Petersburg

"SHAI Republican Clinical Hospital of the Ministry of Health of the Republic of Tatarstan", Kazan'

"SBHI City Clinical Hospital № 4 of the city of Orenburg", Orenburg

"FSBI Nizhny Novgorod Research Institute of Traumatology and Orthopedics of the Ministry of Health of the Russian Federation", Nizhny Novgorod